Versant Venture Capital VI, L.P. — insider trades

Stock trades Versant Venture Capital VI, L.P. reported on SEC Form 4 at LENZ LENZ Therapeutics, Inc., LVTX LAVA Therapeutics NV, GLUE Monte Rosa Therapeutics, Inc..

• Sep 30, 2025: sold 224,974 shares of LENZ LENZ Therapeutics, Inc. ($10.4M)
• Sep 19, 2025: sold 2,903,403 shares of LVTX LAVA Therapeutics NV ($4.06M)
• Sep 18, 2025: sold 135,304 shares of LENZ LENZ Therapeutics, Inc. ($5.71M)
• Sep 18, 2025: sold 1,684,434 shares of LVTX LAVA Therapeutics NV ($2.50M)
• Aug 26, 2025: sold 188,094 shares of LENZ LENZ Therapeutics, Inc. ($7.42M)
• Aug 18, 2025: sold 260,713 shares of LENZ LENZ Therapeutics, Inc. ($10.3M)
• Jul 10, 2025: sold 191,376 shares of LENZ LENZ Therapeutics, Inc. ($6.51M)
• Jun 27, 2025: sold 200,000 shares of LENZ LENZ Therapeutics, Inc. ($6.09M)
• Jun 20, 2025: sold 334,801 shares of LENZ LENZ Therapeutics, Inc. ($10.1M)
• Jun 10, 2025: sold 350,000 shares of LENZ LENZ Therapeutics, Inc. ($10.2M)